Genth-Zotz S et al. Recombinant growth hormone therapy in patients with ischemic cardiomyopathy: effects on hemodynamics, left ventricular function, and cardiopulmonary exercise capacity. Circulation. 1999 Jan 5-12; 99(1):18-21
Ghigo E et al. Diagnosis of adult GH deficiency. Growth Horm IGF Res. 2008 Feb; 18(1):1-16.
Gibney et al. The effects of 10 years of GH in adult GH deficient patients J Endocrin Metab 1999 August
Gilchrist FJ et al. The effect of long-term untreated growth hormone deficiency (GHD) and 9 years of GH replacement on the quality of life (QoL) of GH-deficient adults. Clin Endocrinol (Oxf) 2002 Sep; 57(3):363-70
Gillberg, P. et al. Two Years of Treatment with Recombinant Human Growth Hormone Increases Bone Mineral Density in Men with Idiopathic Osteoporosis J Clin Endocrinol Metab 2002 87: 4900-4906
Gotherstrom G et al. A prospective study of 5 years of GH replacement therapy in GH-deficient adults: sustained effects on body composition, bone mass and metabolic indices. J Clin Endocrinol Metab 2001 Oct; 86(10):4657-65
Giustina A, Barkan A, Chanson P, Grossman A, Hoffman A, Ghigo E, Casanueva F, Colao A, Lamberts S, Sheppard M, Melmed S; Pituitary Society; European Neuroendocrine Association. Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults. J Endocrinol Invest. 2008 Sep;31(9):820-38. Review
Harris, et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003 Oct 15; 115(6):429-35.
Hedstrom M. Hip fracture patients, a group of frail elderly people with low bone mineral density, muscle mass and IGF-I levels. Acta Physiol Scand 1999 Dec; 167(4):347-50
Yusuke Higashi, Sergiy Sukhanov, Asif Anwar, Shaw-Yung Shai, Patrice Delafontaine. “Aging, Atherosclerosis, and IGF-1.” J Gerontol A Biol Sci Med Sci (2012) 67A (6): 626-639.
Ho KK et al. Regulating of growth hormone sensitivity by sex steroids: implications for therapy. Front Horm Res. 2006;35:115-28
Hong J et al.; IGFBP-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 2002 Jan 9, 2002
Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem. 2010 Sep 24;285(39):30233-46.
Isgaard J et al.GH improves cardiac function in rats with experimental MI. Eur J Clin Invest 1997;27:517-
Isley WL. Growth hormone therapy for adults: not ready for prime time?Ann Intern Med 2002 Aug 6;137(3):190-6
Janssen, Y et al. A Switch from Oral (2 mg/Day) to Transdermal (50 mg/Day) 17b-Estradiol Therapy Increases Serum Insulin-Like Growth Factor-I Levels in Recombinant Human Growth Hormone (GH)-Substituted Women with GH Deficiency. J. Clin Endo Metab. 85: January 2000
Jenkins PJ, Mukherjee A, Shalet SM. Does growth hormone cause cancer? Clin Endocrinol (Oxf). 2006 Feb;64(2):115-21.
Johannsson G et al. GH treatment of abdominally obese men reduces abdominal fat mass, improves glusoce and lipoprotein metabolism and reduces diastolic BP. J Clin Endocinol Metab 1997;82:727-734
Johansen et al. Ipamorelin a new ghrp induces longitudinal bone growth in rats. GH and IGF Research 1999, 9 106-113
Johnsen P. et al. Insulin-Like Growth Factor (IGF) I, -II, and IGF Binding Protein-3 and Risk of Ischemic Stroke J Clin Endocrinol Metab 2005 90: 5937-5941;
Kelley KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J, Walker EB. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci U S A. 1986;83:5663-5667.
Khansari DN et al. Effects of long-term, low-dose growth hormone therapy on immune function and life expectancy of mice. Mech Ageing Dev 1991 Jan; 57(1):87-100
Kishimoto I, Tokudome T, Hosoda H, Miyazato M, Kangawa K. Ghrelin and cardiovascular diseases. J Cardiol. 2012 Jan;59(1):8-13.
Kurek R et al. The significance of serum levels of insulin-like growth factor-1 in patients with prostate cancer BJU Int 2000 Jan; 85(1):125-9
Lang CH et al. Cytokine inhibition of JAK-STAT signaling: a new mechanism of growth hormone resistance. Pediatr Nephrol. 2004 Nov 10
Laughlin GA et al. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2004 Jan; 89(1):114-20
Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2004 Jan;89(1):114-20.
Leal-Cerro A The growth hormone (GH)-releasing hormone-GH-insulin-like growth factor-1 axis in patients with fibromyalgia syndrome. J Clin Endocrinol Metab. 1999 Sep; 84(9):3378-81.
Liu H, Bravata DM, Olkin I, Nayak S, Roberts B, Garber AM, Hoffman AR. Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med. 2007;146:104-115.
Liu QL, Wang YS, Wang JX. Effect of growth hormone on the immune function of dendritic cells. Chin Med J (Engl). 2010;123:1078-1083.
Longobardi, S et al Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. J Endocinol Invest, May 1999
Major J et al. Insulin-Like Growth Factor-I and Cancer Mortality in Older Men The Journal of Clinical Endocrinology & Metabolism Vol. 95, No. 3 1054-1059 March 2010
Marcell TJ et al. Oral arginine does not stimulate basal or augment exercise-induced GH secretion in either young or old adults. Gerontol A Biol Sci Med Sci 1999 Aug; 54(8):M395-9
Mitsi AC et al. Early, intracoronary growth hormone administration attenuates ventricular remodeling in a porcine model of myocardial infarction. Growth Horm IGF Res. 2006 Apr; 16(2):93-100
Mitsi AC et al. Early, selective growth hormone administration may ameliorate left ventricular remodeling after myocardial infarction. Med Hypotheses. 2005; 64(3):582-5
Molitch ME. Diagnosis of GH deficiency in adults--how good do the criteria need to be? J Clin Endocrinol Metab. 2002 Feb;87(2):473-6.
Moyle GJ, Daar ES, Gertner JM, Kotler DP, Melchior JC, O'brien F, Svanberg E; Serono 9037 Study Team. Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2004 Apr 1;35(4):367-75.
Muniyappa R et al. Long-Term Testosterone Supplementation Augments Overnight Growth Hormone Secretion in Healthy Older Men. Am J Physiol Endocrinol Metab. 2007
Munzer T et al., Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. J Clin Endocrinol Metab 2001 Aug; 86(8):3604-10
Nam
